James Treanor is a seasoned C-Suite Executive and Board Member with extensive experience in the biotechnology industry. Currently serving as an advisor for multiple companies, including Switch Therapeutics and Molecular Symphony, James has also held significant roles such as CEO at ADRx, Inc. and CSO at Neuron23. With a robust educational background including a Ph.D. in Molecular Neurobiology from the University of Bristol, James has developed expertise in Neuroscience, Drug Development, and Translational Medicine throughout their career, which includes leadership positions at Amgen and a postdoctoral role at Genentech Inc.
This person is not in the org chart
This person is not in any teams
This person is not in any offices